Abstract Review Results

Thank you to all authors for submitting an overwhelming number of abstracts for EuroCMR 2016. The Abstract Review Committee has aimed to accept as many abstracts as possible and integrate them into the program schedule.

Below you can look up all accepted abstracts by ABSTRACT ID and TITLE. All authors will get detailed information soon on how they will be invited to present their abstracts, as part of some of the abstract sessions or through paper/eposter presentations throughout the meeting.

Please note that in order to being able to present your abstract, you need to be on-site. Therefore we kindly ask you to register using our online form. Early registration fees still apply until 14 February.

Abstract ID Abstract Title
1321 Comparison of transthoracic echocardiography versus cardiac magnetic for implantable cardioverter defibrillator therapy in primary prevention strategy dilated cardiomyopathy patients
1322 Computed tomography coronary angiography versus stress cardiac magneTtc resonance for the management of symptomatic revascularized patients: a cost effectiveness study (STRATEGY study)
1323 Evaluation of right ventricular transverse strain and strain rate in patients with acute ST-segment elevation myocardial infarction: a cardiac magnetic resonance feature tracking study
1328 Impact of New Cerebral Ischemic Lesions On the Occurrence of Delirium after Transcatheter Aortic Valve Implantation
1329 Heart T2* assessment to measure iron overload using different software tools in patients with Thalassemia Major
1330 Mechanistic links between epicardial and hepatic fat accumulation, insulin resistance , and cardiac and hepatic structural and functional changes of diabetes in the absence and the presence of obesity
1332 Hypertrabeculated Left Ventricle at Cardiac Magnetic Resonance Imaging: ? -Thalassemia Major vs. Left Ventricular Non -Compaction Disease
1333 Cardiac resynchronization in ischemic heart failure patients: a comparison between therapy guided by cardiac magnetic resonance imaging and 2D-speckle tracking echocardiography.
1334 Patterns of late gadolinium enhancement in Brugada syndrome
1335 Aortic Regurgitation following Transcatheter Aortic Valve Implantation (TAVI): a CMR Study of two prosthesis designs
1336 Incremental value of semi-quantitative evaluation of myocardium perfusion with 3T stress cardiac MRI
1338 Cardiac magnetic resonance versus bisphosphonate scintigraphy for diagnosis of cardiac amyloidosis.
1339 Comparison of low- versus high-dose of gadobutrol for late gadolinium enhancement imaging at 1.5 Tesla: a clinical feasibility study.
1340 Pathological correlates of left bundle branch disease in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance study
1341 Strain relaxation index, a novel tagged MRI-derived diastolic function parameter, is impaired in metabolic syndrome
1342 Myocardial remodelling and fibrosis in nonischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance
1343 Left ventricular morphological quantification with single shot and free-breathing SSFP cine imaging compared with standard breath-hold SSFP cine imaging.
1344 Changes of cardiac iron and function during pregnancy in transfusion-dependent thalassemia patients
1346 Significant improvement of survival by T2* MRI in thalassemia major
1347 Multi-parametric Cardiac Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Intermedia: a Prospective Multicenter Study
1349 Global Longitudinal Strain Predicts Chronic Myocardial Infarction in Patients with Normal Ejection Fraction
1350 The impact of trans-catheter aortic valve implantation induced left-bundle branch block on cardiac reverse remodelling
1351 Value of magnetic resonance myocardial perfusion imaging in patients with indeterminate coronary computed tomography angiography results
1352 Optimal Dose Of Dobutamine During Low-Dose Dobutamine Stress Echocardiography In Correctly Identify Viable Segments On Cardiovascular Magnetic Resonance
1353 Gender differences in response to Transcatheter Aortic Valve implantation in patients with severe aortic stenosis assessed by feature tracking
1354 A qualitative assessment of first-pass perfusion bolus timings in the assessment of myocardial ischemia: A magnetic resonance study.
1355 MRI prospective survey on cardiac iron and function and on hepatic iron in non transfusion-dependent thalassemia intermedia patients treated with desferrioxamine or non chelated.
1356 Proximal aortic stiffening in Turner is more pronounced in the presence of a bicuspid valve
1358 CORONARY CALCIFICATION COMPROMISES MYOCARDIAL PERFUSION IRRESPECTIVE OF LUMINAL STENOSIS
1359 Non-contrast three-dimensional magnetic resonance imaging for pre-procedural assessment of aortic annulus dimensions in patients undergoing transcatheter aortic valve implantation
1360 “Systolic ventricularization” of the left atrium with bileaflet mitral valve prolapse: impact on quantification of mitral regurgitation
1361 CMR assessment of left ventricular remodeling 6 months after percutaneous edge-to-edge repair using Mitraclip
1362 Cardiac Involvement in Patients With Different Rheumatic Disorders
1363 Accuracy of Transthoracic Echocardiography in comparison of Cardiac Magnetic Resonance in the assessment of proximal aortic dilatation
1364 Reduced infarct-adjacent wall thickening and impaired restperfusion in the area at risk of successfully reperfused acute myocardial infarction.
1366 Gender differences in the development of CMR abnormalities and cardiac complications: a multicentric prospective study in a large cohort of thalassemia major patients
1368 Absolute wall thickening and left ventricular ejection fraction – a unifying theory of myocardial contraction and heart failure?
1370 Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention - a randomized three-years follow-up trial
1371 Accuracy and Inter-changeability in Left Ventricular Quantification by Multi-modality Imaging compared to Cardiac Magnetic Resonance: a Systematic Review and Meta-analysis
1373 Reliability and reproducibility of trans-valvular flow measurement by 4D flow magnetic resonance imaging in acute myocardial infarct patients: two centre study.
1374 CMR for myocardial iron overload assessment: a new calibration curve from the MIOT project
1375 Evaluation of Tissue Changes in Remote Noninfarcted Myocardium after Acute Myocardial Infarction using T1-mapping
1376 TRANSIENT ST ELEVATION IN ACS LIKE MYOCARDITIS
1377 Right ventricular long axis strain – The prognostic value of a novel parameter in non-ischemic dilated cardiomyopathy using standard cardiac magnetic resonance imaging
1379 Patients after Fontan with a “total cavopulmonary connection” Fontan modification develop more collateral flow compared to “old-fashioned” Fontan modifications.
1381 CAN SPECKLE TRACKING IMAGING REVEAL MYOCARDIAL IRON OVERLOAD IN THALASSEMIA MAJOR? A COMBINED ECHOCARDIOGRAPHY AND CARDIAC MAGNETIC RESONANCE STUDY
1382 Native myocardial T1 mapping in patients with pulmonary hypertension and age matched volunteers.
1384 A Insidious Line Between Thalassemia Intermedia And Left Ventricular Non-Compaction Disease: The Role Of Cardiac Magnetic Resonance
1385 Longitudinal strain assessment in dilated cardiomyopathy patients using a novel accelerated DENSE sequence
1386 A comparison of circumferential strain results from multiple software packages in healthy subjects
1387 A MRI-derived 3D patient specific model for fibrosis quantification in atrial fibrillation
1388 Pulmonary Artery : Ascending Aorta Diameter - An Important and Easily Measureable Prognostic Parameter
1389 The role of the right ventricular insertion point in heart failure patients with preserved ejection fraction: Insights from a cardiovascular magnetic resonance study
1391 Scar burden and survival in patients with ischemic cardiomyopathy and poor LV ejection fraction
1392 Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST- elevation myocardial infarction
1393 Validation of aortic in-vitro strain measurement by Magnetic Resonance Imaging with realistic abdominal aortic aneurism phantom
1394 Novel carotid artery ultrasound index - Extra-media thickness and a well-established cardiac magnetic resonance fat quantification method.
1395 Infarct size following treatment with second-generation versus third-generation P2Y12 antagonists in patients with multivessel coronary disease at STEMI in the CvLPRIT study
1398 Myocardial fibrosis associates with B-type natriuretic peptide levels and outcomes more than wall stress.
1403 Validation of CMR-derived LVOT diameters against direct in-vivo measurement
1406 Equivalence of segmented conventional and fast single-shot late gadolinium enhancement (LGE) techniques for quantitative evaluation of fibrosis in ischemic and non-ischemic cardiac disease
1407 simultaneous T1 and T2 cardiac quantification with CABIRIA: initial clinical experience
1408 THE ROLE OF CARDIAC MAGNETIC RESONANCE IMAGING IN PATIENTS WITH CARCINOID HEART DISEASE
1409 Early myocardial perfusion measured by CMR in acute myocardial infarction treated by primary PCI - a postconditioning study
1410 CARDIAC MRI APPEARANCES OF TUBERCULOSIS - A REVIEW OF VARIED PRESENTATIONS IN INDIA
1411 The association between fibrosis and contractile dysfunction in hypertrophic cardiomyopathy
1412 Myocardial partition coefficient of gadolinium: A comparison between patients with acute myocarditis, chronic infarction and healthy volunteers
1415 Atheroma burden, cardiac remodelling and epicardial fat: A comparison between healthy South Asian and European adults using Whole Body Cardiovascular MR
1416 Cardiac magnetic resonance predicts atrial fibrillation occurrence in patients with hypertrophic cardiomyopathy.
1418 Symptomatic Ventricular Arrhythmias: Diagnostic Yield of Cardiac Magnetic Resonance
1420 Assessment of paravalvular aortic regurgitation after transcatheter aortic valve implantation using cardiac magnetic resonance imaging: a comparative study with echocardiography and angiography
1421 Assessment of aortic stiffness in asymptomatic low risk patients with type 2 diabetes mellitus
1422 Left atrial strain measured by feature tracking predicts left ventricular end diastolic filling pressure
1423 Head-to-head comparison of acceleration algorithms in 4-dimensional flow CMR
1426 Validation of extracellular volume equation by serial cardiac magnetic resonance imaging measurements in patients with varying hematocrit
1427 Assessing diastolic function applying Cardiovascular Magnetic Resonance - comparison with the gold standard
1435 Association of Smoking with Myocardial Injury and Clinical Outcome in Patients Undergoing Mechanical Reperfusion for ST-Elevation Myocardial Infarction
1436 Shock index as a predictor of myocardial damage and clinical outcome in ST-elevation myocardial infarction
1451 Combined biomarker testing for the prediction of microvascular obstruction after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
1452 A novel oscillometric technique compared with cardiac magnetic resonance for the assessment of aortic pulse wave velocity in ST-segment elevation myocardial infarction
1456 Aorto-pulmonary collaterals evaluated by CMR is associated to reduced 'effective' cardiac index late after Fontan palliation
1457 Cardiac MRI Under Percussive Ventilation: A New Promising Technique
1458 Evaluation of pulmonary transit time and Pulmonary Blood Volume with first-pass perfusion CMR imaging in adult with repaired Congenital Heart disease
1459 Prognostic value of the cardiac magnetic resonance as a predictor of improvement in ventricular function after TakoTsubo syndrome
1461 Prognostic value of Cardiovascular Magnetic Resonance derived indexes of myocardial fibrosis in heart transplant recipients.
1462 Diagnostic performance of ECG detection of left atrial enlargement in patients with arterial hypertension relative to the cardiac magnetic resonance gold-standard: impact of obesity
1463 Utility of cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis and prediction of therapeutic effects in patients with complete heart block and implanted magnetic resonance-conditional pacemaker: A multicenter study
1464 Cardiac Amyloidosis and Aortic Stenosis - The Convergence of Two Aging Processes
1467 Cardiac magnetic resonance late gadolinium enhancement in patients with genetic dilated cardiomyopathy
1469 T1 and T2 mapping cardiovascular magnetic resonance to monitor inflammatory activity in patients with myocarditis
1471 Left ventricular hypertrophy in hypertensive patients - comparison of Cardiac Magnetic Resonance and Echocardiographic analysis of morphological and functional LV-parameters.
1472 Is Angiographic Perfusion Score assessed in patients with acute myocardial infarction correlated with Cardiac Magnetic Resonance infarct size and N-terminal pro-brain natriuretic peptide in 6-month follow-up.
1474 A novel method of Segment Length Tracking providing regional strain measures from standard CMR cine images in CRT candidates
1475 ROLE OF ADENOSINE STRESS CARDIAC MRI IN THE SETTING OF CHRONIC TOTAL OCCLUSION OF CORONARY ARTERIES
1476 Cardiac Magnetic Resonance Patterns of Left Ventricular Diastolic Function In Hypertrophic Cardiomyopathy
1477 Impact of platelet volume on thrombus burden and tissue reperfusion in patients with STEMI treated with primary angioplasty: MRI study.
1478 Prognostic Value of Pulmonary Blood Volume by Contrast-Enhanced Magnetic Resonance Imaging in Heart Failure Outpatients – The PROVE-HF Study
1479 Right ventricle systolic function assessment and its prognostic implications in cardiac amyloidosis
1480 Impact of electronic coaching on cardiovascular risk reduction in a high-risk primary prevention population - A cardiovascular magnetic resonance sub-study
1483 Mitral valve prolapse:arrhythomogenic substrates by cardiac megnetic resonance imaging
1484 Cardiac MRI - an important tool in the evaluation of multsystemic inflamatory diseases. An Erdheim-Chester Disease case report
1485 Predictive value of cardiac magnetic resonance for future adverse cardiac events in patients with ST-segment elevation myocardial infarction
1486 Time-to-treatment but not thrombectomy influence infarct size and microvascular obstruction in patients with acute ST-segment elevation myocardial infarction treated with primary coronary intervention.
1489 Primary PCI versus Early Routine Post Fibrinolysis PCI for ST Elevation Myocardial Infarction
1490 Evaluation of ventricular function in Fontan patients undergoing feature tracking magnetic resonance strain
1491 Impacts of atrialized right ventricle and left ventricular displacement in Ebstein's anomaly on left ventricular function assessed by cardiovascular MRI
1492 Myocardial Perfusion Reserve and Global Longitudinal Strain in Early Rheumatoid Arthritis
1493 First Pass Perfusion Reserve Index in Paediatric Patients with Arterial Switch for Transposition of Great Arteries
1494 Final diagnosis for patients presenting with chest pain, troponin rise, electrocardiographic changes and normal coronary arteries: insights from Cardiovascular MRI in our population.
1495 Early Predictive Factors of LV Remodeling after STEMI; Assessment by Coronary Angiogram and Cadiovascular Magnetic Resonance
1496 Myocardial substrates underlyng early ventricular arrhythmias in ST-elevation acute myocardial infarction: the role of cardiac megnetic resonance
1497 The pathobiologic mechanisms and the prognostic meaning of T wave inversion in acute myocarditis. A study perfomed by cardiac magnetic resonance
1498 Cardiac magnetic resonance: diagnostic and therapeutic impact on suspected acute coronary syndrome with near normal coronary angiography
1499 Acute coronary syndrome with normal coronary angiography: a gender issue?
1500 Exercise CMR to differentiate athlete’s heart from patients with early dilated cardiomyopathy
1501 The Influence of Left Atrial Function on Exercise Tolerance in Patients with Heart Failure and Preserved Ejection Fraction: A Cardiac Magnetic Resonance Feature Tracking Study
1502 Left ventricular function and size evaluated by hybrid cardiac positron emission tomography-magnetic resonance: Intraindividual comparison of left ventricular ejection fraction and ventricular volumes derived by two modalities.
1503 Flow pattern and vascular distensibility of the pulmonary arteries in patients after repair of tetralogy of Fallot. Insights from 4D flow CMR
1504 Microvascular Obstruction in Patients with Anterior ST-Elevation Myocardial Infarction who Underwent Primary Percutaneous Coronary Intervention: Predictors and Impact on the Left Ventricular Function
1507 Cardiac Magnetic Resonance measured Extracellular Volume Independently Predicts Adverse Outcome in Heart Failure with Preserved Ejection Fraction
1508 Histological Validation of ECV Quantification by Cardiac Magnetic Resonance T1 Mapping in Cardiac Amyloidosis
1509 Influence of non-invasive hemodynamic CMR parameters on maximal exercise capacity in surgically untreated patients with Ebstein’s anomaly
1510 Left Atrium assessed by Cardiovascular Magnetic Resonance at 1.5 and 3 Tesla – age and gender effects
1511 Risk stratification in sarcoidosis: Incidence of cardiac sarcoidosis in individuals diagnosed with extra-cardiac disease by cardiovascular magnetic resonance
1513 Comparative Evaluation of Flow Quantification Across the Atrioventricular Valve in Patients with Functional Univentricular Heart After Fontan’s Surgery and Healthy Controls: Measurement by 4D Flow Magnetic Resonance Imaging and Streamline Visualizati
1514 Comparison of Free Breathing Cardiac MRI Radial technique to the Standard Multi breath-hold cine SSFP CMR technique for the assessment of LV Volumes and Function.
1515 Does arterial switch for d-transposition of the great arteries alter myocardial deformation of the ventricles?
1516 Myocardial deformation characteristics of the systemic right ventricle after atrial switch operation for transposition of the great arteries
1520 Aortic Elasticity Indexes by Magnetic Resonance Predict Progression of Ascending Aorta Dilation
1521 Prognostic Value of Pulmonary Blood Volume by Contrast-Enhanced Magnetic Resonance Imaging in Heart Failure Outpatients
1522 Combined atrioventricular assessment of diastolic function by cardiac magnetic resonance
1523 The role of CMR in the acute phase of hospitalization: changing paradigms
1527 Accuracy of T1 Mapping by multi-professional CMR operators to predict myocardial infarct
1531 Detecting hypertensive heart disease: the additive value of cardiovascular magnetic resonance imaging
1534 DIAGNOSTIC PERFORMANCE OF CARDIAC MAGNETIC RESONANCE STRAIN PARAMETERS IN ASSESMENT OF MYOCARDIAL ISCHEMIA .
1535 Relationships between left ventricular filling pressures and longitudinal dysfunction with myocardial fibrosis in uncomplicated hypertensive patients
1536 Self-navigated free-breathing isotropic 3D whole heart phase sensitive inversion recovery magnetic resonance without navigator for detection of myocardial infarction
1537 Safety, image quality and clinical utility of cardiac magnetic resonance in patients with antiarrhythmic devices.
1538 Usefulness of cardiac magnetic resonance to predict the need for surgical procedures in patients with mitral regurgitation.
1539 PREDICTIVE CLINICAL FACTORS OF TISSUE DAMAGE SEVERITY IN REPERFUSED ACUTE MYOCARDIAL INFARCTION AS VISUALIZED BY CARDIAC MAGNETIC RESONANCE.
1541 Which CMR derived parameter predicts better the need of invasive treatment in aortic coarctation?
1542 Preoperative CMR-based score predict ventricular response after surgical left ventricular reconstruction in ischemic heart failure patients
1543 Contrast-enhanced magnetic resonance tomography in patients with supraventricular tachyarrhythmias
1546 Prognostic Value of CMR Imaging Biomarkers on Outcome in Peripheral Arterial Disease: a 6-year Follow-up Pilot Study
1547 Assessment of Right Ventricular Strain Using Myocardial Deformation Recovery Semi Automated Technique: Initial Experience and Normal Values
1549 Dobutamine-Stress-CMR in Young Adults after Arterial Switch Operation as Neonates
1550 Normal T1, T2, T2* and extracellular volume reference values in healthy volunteers at 3 Tesla cardiac magnetic resonance.
1551 Comprehensive intra-ventricular myocardial deformation strain analysis in healthy volunteers: implications for regional myocardial disease processes
1553 Impact of posteromedial papillary muscle infarction on mitral regurgitation after ST-segment elevation myocardial infarction
1555 Excellent response rate to cardiac resynchronization therapy guided with magnetic resonance imaging
1556 Role of cardiac magnetic resonance imaging in assessment of left ventricular hypertrophy
1557 Elastic properties changes of aorta in patients with dilatation of the ascending aorta evaluated by Magnetic Resonance
1558 The prevalence of active myocarditis assessed by cardiovascular magnetic resonance in patients with clinically suspected myocarditis.
1559 REAL TIME, X-MRI GUIDANCE TO OPTIMISE LEFT VENTRICULAR LEAD PLACEMENT FOR DELIVERY OF CARDIAC RESYNCHRONISATION THERAPY.
1560 The role of Cardiac magnetic resonance imaging in patients undergoing ablation for ventricular tachycardia- Defining the substrate and visualizing the outcome
1561 Detection of coronary stenosis at rest using Blood Oxygen-Level Dependent Magnetic Resonance Imaging
1563 Quantitative assessment of myocardial scar heterogeneity using texture analysis to risk stratify post-MI patients for ICD insertion
1564 Gender differences in exercise capacity and LV remodeling in response to pressure overload in aortic stenosis.
1565 Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis.
1566 Semiquantitative analysis of low and high b value DWI for detecting myocardial edema in acute myocarditis
1567 Value of Cardiac MRI In Detecting Coronary Artery Disease In Newly Diagnosed Systolic Dysfunction
1569 Using intrinsic Cardiac Shear Waves to measure Myocardial Stiffness: Preliminary results from Patients with Heart failure with preserved Ejection Fraction
1570 USEFULNESS OF CARDIAC MAGNETIC RESONANCE IN TUBEROUS SCLEROSIS COMPLEX
1571 Relationship of cerebrovascular reactivity and MRI pattern of carotid atherosclerotic plaque
1572 Myocardial wall stress as a novel CMR measure to assess cardiac function
1573 Feature tracking cardiac magnetic resonance to assess LV mechanics in pressure and volume overload
1574 Safety, feasibility and clinical impact of Cardiovascular Magnetic Resonance in patients with MR-conditional devices
1575 Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1
1576 T1 Mapping at 1-Year Following Aortic Valve Replacement: Baseline Geometry Defines Magnitude of Fibrosis Regression
1577 Feasibility study of an MR conditional pedal ergometer for cardiac stress MRI
1578 Papillary muscles offer further insight into hypertrophied hearts: a cardiovascular magnetic resonance study
1580 Correlation between circulating microRNA 29 and diffuse myocardial fibrosis, assessed by T1 mapping, in patients affected by non ischemic dilative cardiomyopathy.
1581 Pulmonary valve replacement for severe pulmonary stenosis has a positive effect on left ventricular remodeling.
1582 The RV after cardiac surgery, more resilient than thought: multiparametric quantification shows altered rather than reduced function
1583 Normal values of LV global myocardial mechanics using two and three-dimensional cardiovascular magnetic resonance
1584 Usefulness of cardiovascular magnetic resonance to differentate coronary artery disease from non ischemic cardiomyoptathy in patients with heart failure
1585 Prediction of infarct transmurality in acute myocardial infarction based on cardiac magnetic resonance deformation analysis
1586 Tissue tracking myocardial deformation analysis and prediction of left ventricular remodeling in acute myocardial infarction
1587 4-dimensional Proximal Flow Convergence Analysis by Magnetic Resonance Imaging for Assessment of Mitral Regurgitation Severity, compared to echo-Doppler
1588 Insights into hypertensive heart disease phenotypes: spectrum of myocyte, interstitial and vascular changes by cardiovascular MRI.
1589 Investigating strategies for optimal 31P MRS clinical cardiac at 3T: Initial Results
1590 Impact of cardiovascular magnetic resonance on clinical management and decision-making of out of hospital cardiac arrest survivors with inconclusive coronary angiogram
1591 Detailed Left Atrial Assessment in Anderson Fabry Disease
1593 What does CMR add to the ESC Risk Prediction Model to Assess the Occurrence of Sudden Cardiac Death in Patients with HCM?
1595 Measuring invasive blood pressure by catheters guided solely by Cardiovascular Magnetic Resonance by using a new guidewire without the need of a hybrid CMR-fluoroscopy suite
1596 Increased local wall shear stress after coarctation repair is associated with descending aorta pulse wave velocity: evaluation with CMR and 4D flow
1597 Detecting Progression of Diffuse Interstitial Fibrosis in Alstrom Syndrome.
1598 Anatomical and functional evaluation of postinterventional pulmonary vein stenosis by magnetic resonance imaging
1599 Influence of active and passive cardiac implants on CMR image quality : results from a consecutive patient series
1600 Reproducibility of aortic 4D flow measurements in healthy volunteers
1601 An automatic approach to extract 4D flow hemodynamic markers: application in BAV-affected patients
1602 Global myocardial mechanics with 2 and 3-Dimensional cardiovascular magnetic resonance feature tracking in patients with myocarditis
1603 A CMR-based clinician-friendly assessment of in vivo left ventricle hemodynamics
1604 Reproducibility of left atrial strain using cardiovascular magnetic resonance myocardial feature tracking
1605 The severity of myocardial infarction in STEMI, determined by transmurality of infarct and infarct characteristics, impacts on myocardial T2 values.
1606 MicroRNA as potential biomarkers of acute myocardial damage following STEMI.
1607 Myocardial blush grade is associated with microvascular obstruction on CMR following STEMI.
1608 4D Flow CMR imaging: Comparison of conventional parallel imaging and variable density k-t acceleration
1609 In-vitro comparison of segmented-gradient-echo versus non-segmented echo planar imaging 4D Flow CMR: validation of flow volume and 3D vortex ring assessment
1612 Diffuse fibrosis in the ventricles of patients with transposition of great arteries late after atrial switch
1614 Not just 2D but also 4D flow measurements in pulsatile phantom are accurate and reproducible
1615 Diffusion Tensor Imaging: Comparison of Hypertrophic Cardiomyopathy, Hypertension and Healthy Cohorts
1620 Quantitative Criteria for the Diagnosis of the Congenital Absence of Pericardium by Cardiac Magnetic Resonance
1622 Persistent myocardial inflammation due to intramyocardial haemorrhage in reperfused STEMI as a precursor to adverse LV remodelling - insights from multi-parametric mapping
1623 T1 mapping can quantify the area-at-risk and infarct size – no need for T2 mapping or conventional LGE imaging in acute STEMI at 1.5T
1624 Impact of myocardial fibrosis measured by cardiac magnetic resonance imaging on reverse left ventricular remodelling after transcatheter aortic valve implantation
1625 Prosthetic valve regurgitation after transcatheter aortic valve implantation with new-generation devices compared to surgical aortic valve replacement – a cardiac magnetic resonance imaging flow measurement analysis
1626 The ECG as a predictor of arrhythmogenic substrate on Cardiac Magnetic Resonance Imaging in patients undergoing ablation for premature ventricular contractions
1627 Diagnostic and clinical implications of CMR timing (early versus late) in patients with troponin positive acute coronary syndromes and unobstructed coronary arteries
1630 Blood T1 variability explained in healthy volunteers: an analysis on MOLLI, ShMOLLI and SASHA.
1631 Utility of Cardiac Magnetic Resonance in the diagnosis and stratification of arrhythmic risk in patients with confirmed or suspected ventricular arrhythmias
1632 Widespread tissue injury during acute myocardial infarction: evidence from advanced CMR relaxometry
1633 Three-dimensional vortex formation in patients with a Fontan circulation: evaluation with 4D flow CMR
1634 Role of cardiac magnetic resonance in the diagnosis of ARVC/D mimics
1635 Size matters: pulmonary veins geometry by cardiac magnetic resonance imaging in atrial fibrillation patients.
1636 Three-dimensional wall shear stress assessed by 4Dflow CMR in bicuspid aortic valve disease
1637 Assessment of Aortic and Pulmonary Artery stiffness in Patients with COPD using Cardiac Magnetic Resonance
1638 Myocardial Mechanics implications using 2D Cardiovascular Magnetic Resonance in Aortic Regurgitation.
1639 Delineation of myocardial infarction & viability by 12 lead ECG vs cardiac magnetic resonance
1640 Assessing the risk of late cardiotoxicity in low risk breast cancer survivors receiving contemporary anthracycline treatment: a 6 year 100 patient study.
1641 Regional variation in native T1 values in normal healthy volunteers?
1642 How do the differences in Left Ventricular wall measurements from Echocardiography and CMR in patients with Hypertrophic Cardiomyopathy affect current Sudden Cardiac Death Risk Scores?
1644 Histological Validation of Cardiac Magnetic Resonance for the Evaluation of Myocardial Fibrosis after Heart Transplantation in Children
1645 Feasibility of myocardial strain assessment using tissue tracking at 3.0T CMR following ST-segment elevation myocardial infarction
1646 Comparison of T1-mapping, T2-weighted and contrast-enhanced cine imaging at 3.0T CMR for diagnostic oedema assessment in ST-segment elevation myocardial infarction
1648 Diagnostic Impact of Cardiac Magnetic Resonance in patients with acute chest pain, troponin elevation and no significant angiographic coronary artery disease
1649 Comparison of T1-mapping at 3.0T CMR and angiographic APPROACH score for area at risk assessment in ST-segment elevation myocardial infarction
1651 Noninvasive assessment of intracardiac viscous energy loss in Fontan patients from 4D Flow CMR
1652 Myocardial Fibrosis is Prevalent in Obstructive Sleep Apnea and Associated with Hospitalization for Heart Failure or Death
1653 BEHCET AND MYOCARDIAL INFARCTION: A RARE COMBINATION

 

 
 
© 2015 EACVI/ESC | Sophia Antipolis, France
Congress Organisation and Administration by MEDCONVENT, Vienna, Austria